Stay updated on RT+Nivolumab+Ipilimumab vs RT+Capecitabine Clinical Trial
Sign up to get notified when there's something new on the RT+Nivolumab+Ipilimumab vs RT+Capecitabine Clinical Trial page.

Latest updates to the RT+Nivolumab+Ipilimumab vs RT+Capecitabine Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedNew navigation/section labels were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment label was updated. The revision tag was updated from v3.5.5 to v3.6.0 and new metadata labels Last verified and Last known status was added.SummaryDifference1%

- Check18 days agoChange DetectedThe page shows a new revision tag: Revision: v3.5.5, replacing v3.5.4, indicating a minor update to the page metadata. This change does not alter the trial details, eligibility criteria, or outcomes on the page.SummaryDifference0.0%

- Check39 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, indicating a new page revision in the system. The rest of the page content remains the same.SummaryDifference0.0%

- Check61 days agoChange DetectedThe page’s UI/version label has been updated from revision v3.5.0 to v3.5.3.SummaryDifference0.0%

- Check97 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.0%

- Check111 days agoChange DetectedThe page revision was updated to v3.4.3, adding status metadata and sponsor attribution (Centre Leon Berard). The previous revision was v3.4.2.SummaryDifference0.4%

Stay in the know with updates to RT+Nivolumab+Ipilimumab vs RT+Capecitabine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RT+Nivolumab+Ipilimumab vs RT+Capecitabine Clinical Trial page.